Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Meprin A subunit alpha pseudogene 1 (MEP1AP1) is classified as a pseudogene**, meaning it is a non-functional segment of DNA similar to the working gene for meprin A subunit alpha (MEP1A)[1]. Pseudogenes do not encode functional proteins and are not considered therapeutic targets. There is no evidence that MEP1AP1 is transcribed into a biologically meaningful RNA or protein, nor are there currently known disease associations, biological functions, or drug interactions attributed to it[1][8]. **Key context:** - The *functional* version, meprin A subunit alpha (*MEP1A*), is an active **metallopeptidase** with roles in inflammation and various diseases, but **MEP1AP1 is only a pseudogene** with no known protein product or functional role[1][7]. - MEP1AP1 should not be confused with MEP1A or the related MEP1B, which are genuine protein-coding genes and may be considered targets in some contexts[2][4][7]. **Summary:** "Meprin A subunit alpha pseudogene 1" is a non-functional pseudogene and not a therapeutic target, so most structured fields do not apply or should be left null[1][8].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Meprin A subunit alpha pseudogene 1 (MEP1AP1).